Clinical evidence for therapeutic application of the natriuretic peptides to CKD patients is limited at present, while Sezai et al. showed a possible kidney-protective effect of ANP infused into patients undergoing coronary artery bypass graft surgery [24]. Here, NPPA is linked to chronic kidney disease.